MEDIA RELEASE PR37226
ASP Announces Acquisition of Gloster Europe to Help Reduce Infections in Healthcare Facilities
IRVINE, Calif., Nov. 23 /PRNewswire-AsiaNet/ --
New Area Decontamination Technology Broadens ASP's Portfolio of
Infection Prevention Solutions by Providing Patients with Assurance that
Their Hospital Environment is Disinfected
Advanced Sterilization Products (ASP), a leading global infection prevention solution provider, announced
today the acquisition by its French affiliate, Apsis S.A.S., of Gloster Europe, a privately held developer of
innovative disinfection processes and technologies to prevent healthcare-acquired infections. Terms of the
acquisition were not disclosed.
Gloster Europe designs and markets an innovative area decontamination technology that provides
disinfection of patient environments such as hospital and operating rooms. This technology generates a dry
mist of hydrogen peroxide on all surfaces for broad and efficient disinfection. Gloster Europe's products have
gained significant momentum in Europe and the Middle East and have achieved scientific recognition for their
effectiveness against superbugs, such as MRSA and C.difficile, as well as many other viruses and fungi.
"Area decontamination technology is a perfect strategic complement to ASP's existing portfolio of surgical
instrument sterilization, high-level disinfection and hand hygiene solutions," said Chuck Austin, Worldwide
President of ASP. "Healthcare-acquired infections are a growing global concern. ASP is proud to offer patients
who need hospital care greater peace of mind, knowing their room has the added infection protection benefit
of this advanced and automated disinfection technology."
Never has the need been greater for novel area decontamination technologies with healthcare-acquired
infection rates rising across the globe. Healthcare-acquired infections are at unacceptable rates with an
incidence of 4.5 percent of hospital admissions in the U.S. and Western Europe and as high as 15 percent in
emerging markets.(1)
Gloster Europe's technologies, marketed under the STERINIS(R) brand name, are currently available in
Europe, the Middle East and select countries in Africa and Asia with rapid expansion to other markets planned
for 2010 and beyond, pending country-specific regulations.
About Advanced Sterilization Products (ASP)
Advanced Sterilization Products (ASP) division of Ethicon, Inc., a member of the Johnson & Johnson Family
of Companies, is a leading developer of innovative instrument sterilization, high level disinfection and cleaning
technologies. The company is dedicated to protecting patients, healthcare workers, and the environment with
products that focus as much on safety as they do on efficacy and cost-effectiveness. Utilizing advanced
instrument processing technologies, these products help customers to promote positive patient outcomes
while controlling costs, increasing productivity and enhancing safety. The company is based in Irvine,
California, with offices around the world.
(c) Ethicon, Inc. 2009
(1) Centers of Disease Control and Prevention. Estimates on HealthCare Associated Infections. Available
SOURCE: Advanced Sterilization Products
CONTACT: Media, U.S., Katie Sweet, +1-949-789-3945, ksweet@its.jnj.com, or EMEA, Teresa Mueller,
+33-1-55-00-44-33, tmueller1@its.jnj.com, both of ASP; or Investors, Stan Panasewicz, +1-732-524-2524,
spanase1@its.jnj.com, or Louise Mehrotra, +1-732-524-6491, lmehrot@its.jnj.com, both of Johnson &
Johnson Investor Relations
Translations:
NEWS 
